InVivoMAb anti-mouse IL-6
BE0046
ApplicationsNeutralisation/Blocking
Product group Antibodies
ReactivityMouse
Overview
- SupplierBio X Cell
- Product NameInVivoMAb anti-mouse IL-6
- Delivery Days Customer7
- ApplicationsNeutralisation/Blocking
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDMP5-20F3
- Concentration4-11 mg/ml
- Estimated Purity>95%
- HostRat
- IsotypeIgG1
- ReactivityMouse
- Storage Instruction2°C to 8°C
- UNSPSC12352203
References
- Benevides L, da Fonseca DM, Donate PB, et al. IL17 Promotes Mammary Tumor Progression by Changing the Behavior of Tumor Cells and Eliciting Tumorigenic Neutrophils Recruitment. Cancer Res. 2015,75(18):3788-99. doi: 10.1158/0008-5472.CAN-15-0054Read this paper
- Liang Y, Yang K, Guo J, et al. Innate lymphotoxin receptor mediated signaling promotes HSV-1 associated neuroinflammation and viral replication. Sci Rep. 2015,5:10406. doi: 10.1038/srep10406Read this paper
- Tsukamoto H, Senju S, Matsumura K, et al. IL-6-mediated environmental conditioning of defective Th1 differentiation dampens antitumour immune responses in old age. Nat Commun. 2015,6:6702. doi: 10.1038/ncomms7702Read this paper
- Jose S, Tan SW, Ooi YY, et al. Mesenchymal stem cells exert anti-proliferative effect on lipopolysaccharide-stimulated BV2 microglia by reducing tumour necrosis factor-α levels. J Neuroinflammation. 2014,11:149. doi: 10.1186/s12974-014-0149-8Read this paper
- Khmaladze Ia, Kelkka T, Guerard S, et al. Mannan induces ROS-regulated, IL-17A-dependent psoriasis arthritis-like disease in mice. Proc Natl Acad Sci U S A. 2014,111(35):E3669-78. doi: 10.1073/pnas.1405798111Read this paper
- Hock K, Pilat N, Baranyi U, et al. Donor CD4 T cells trigger costimulation blockade-resistant donor bone marrow rejection through bystander activation requiring IL-6. Am J Transplant. 2014,14(9):2011-22. doi: 10.1111/ajt.12823Read this paper
- Barber DL, Andrade BB, McBerry C, et al. Role of IL-6 in Mycobacterium avium--associated immune reconstitution inflammatory syndrome. J Immunol. 2014,192(2):676-82. doi: 10.4049/jimmunol.1301004Read this paper
- Kugler DG, Mittelstadt PR, Ashwell JD, et al. CD4+ T cells are trigger and target of the glucocorticoid response that prevents lethal immunopathology in toxoplasma infection. J Exp Med. 2013,210(10):1919-27. doi: 10.1084/jem.20122300Read this paper
- Berger H, Végran F, Chikh M, et al. SOCS3 transactivation by PPARγ prevents IL-17-driven cancer growth. Cancer Res. 2013,73(12):3578-90. doi: 10.1158/0008-5472.CAN-12-4018Read this paper
- Debock I, Delbauve S, Dubois A, et al. Th17 alloimmunity prevents neonatal establishment of lymphoid chimerism in IL-4-deprived mice. Am J Transplant. 2012,12(1):81-9. doi: 10.1111/j.1600-6143.2011.03778.xRead this paper
